RIGL Rigel Pharmaceuticals Inc climbs two percent after Q4 2025 results even as EPS falls short of analyst forecasts How OTG OTGA stacks up against analyst expectations Institutional Demand 20260508 CrownReserve CRACR maintains acquisition focus with no major revenue updates in latest period Fortive Corporation FTV Stock Volatility Overview Q4 2025 Earnings Beat Estimates